Biotech China 2014

Leukemia: Memorial Sloan-Kettering Cancer Center

Total Score People Score Events Score
50 43 10
Date Event Presentation Speakers
May 31, 2013 ASCO Annual Meeting 2013 Multimodality Approaches to Achieving Tobacco Cessation in the Oncology Practice Jamie S. Ostroff
Optimizing the Role of Advanced Practice Professionals in Oncology Practice Dean Bajorin
Prostate Cancer Screening: Past, Present, and Future Peter T Scardino, Ethan M. Basch
Relating to Patients on a Humanistic or Spiritual Level: How Physicians Can Make a Difference (M01) Jimmie C Holland
More Mastectomies: Why? (C05) Monica Morrow
Multiplex Genetic Testing for Inherited Cancer Risk: Pros and Cons Mark Robson
Optimizing Locoregional Treatment in Early-Stage Breast Cancer Hiram S. Cody
Education Sessions Robert G Maki, Leonard Saltz
Education Sessions Ethan M. Basch
Education Sessions Kenneth Offit
Education Sessions Andrew David Zelenetz, Stuart M Lichtman, Sergio Giralt
Special Session Teresa Gilewski
April 6, 2013 AACR Annual Meetings CANCER EVOLUTION AND RESISTANCE Neal Rosen
Cross-Species Analysis of Mouse and Human Cancer Chairperson: David J. Adams, Wellcome Trust Sanger Institute, Cambridge, United Kingdom Hans-Guido Wendel
Building on the Success of CTLA-4 Blockade Through Biomarker Analyses and Development of Novel Combinatorial Strategies Chairperson: Jedd D. Wolchok, Memorial Sloan-Kettering Cancer Center, New York, NY Jedd D. Wolchok, Margaret Callahan
Use of Next-Generation Sequencing: Implementation of Clinical Genomics Chairperson: David B. Solit, Memorial Sloan-Kettering Cancer Center, New York, NY David B. Solit
Structural Aberrations in a Thousand Tumors Chairperson: Raju Kucherlapati, Harvard Medical School, Boston, MA Chris Sander
The Molecular Basis for Improvement in Endometrial Cancer Therapy Co-Chairpersons: Cheryl Lyn Walker, Texas A&M University Health Science Center, Houston, TX, and Douglas A. Levine, Memorial Sloan-Kettering Cancer Center, New York, NY Douglas A. Levine
Using Genomics to Guide Cancer Immunotherapy Chairperson: Robert D. Schreiber, Washington University School of Medicine, St. Louis, MO James P Allison
Novel Therapeutic Concepts with Kinases, Immuno-, and Radiotherapy Chairperson: Charles L. Sawyers, Memorial Sloan-Kettering Cancer Center, New York, NY James A. Fagin
Predictive Modeling of Cancer Treatment in Single Patients (N of 1) Moderator: Charles L. Sawyers, Memorial Sloan-Kettering Cancer Center, New York, NY David B. Solit
Clinical Trials Based on Mutations versus Histology Charles L Sawyers
Credentialing Response Biomarkers for Signal Transduction Inhibitors Chairperson: Neal Rosen, Memorial Sloan-Kettering Cancer Center, New York, NY Neal Rosen
Noncoding RNAs in Cancer: From Pathogenesis to Therapeutics Chairperson: Elsa R. Flores, The University of Texas MD Anderson Cancer Center, Houston, TX Andrea Ventura
Tumor-Secreted Factors Chairperson: David C. Lyden, Weill Cornell Medical College of Cornell University, New York, NY David C Lyden
Progress in Targeting Chromatin Modifying Enzymes in Cancer Therapy Victoria M. Richon, Sanofi Oncology, Cambridge, MA Victoria M. Richon
Macrophages as a Therapeutic Target in the Tumor Microenvironment Johanna A. Joyce, Memorial Sloan-Kettering Cancer Center, New York, NY Johanna A. Joyce
August 24, 2012 21st Annual Short Course on Experimental Models of Human Cancer Identifying Molecular Targets for the Treatment of Human Brain Cancer Eric C Holland
January 8, 2012 Chemokines and Leukocyte Trafficking in Homeostasis and Inflammation Visualizing Immune Responses to Toxoplasma gondii in situ Ellen A Robey
March 6, 2011 Stem Cells, Cancer and Metastasis (C4) Priming the Soil: The Pre-Metastatic Niche David C Lyden
February 17, 2011 15th Annual International Congress on Hematologic Malignancies: Focus on Leukemias, Lymphomas, and Myeloma Overall Survival Andrew D. Zelenetz, MD, PhD
Welcome Andrew D. Zelenetz, MD, PhD
Do New Therapies Change the Paradigm for Treatment of Peripheral T-Cell Lymphoma? Steven Horwitz
Comment Steven Horwitz
Myeloproliferative Neoplasms Martin S. Tallman
Can Acute Promyelocytic Leukemia Be Managed Without Chemotherapy? Martin S. Tallman
Afternoon Workshop | Monoclonal Antibodies Andrew D. Zelenetz, MD, PhD
Supportive Care in Hematologic Malignancies Andrew D. Zelenetz, MD, PhD
Lymphoma Steven Horwitz
Chronic Lymphocytic Leukemia Andrew D. Zelenetz, MD, PhD
Tumor Boards | Challenging Cases in Hematologic Malignancies and Attendee-Submitted Cases Andrew David Zelenetz
April 30, 2010 Great Debates and Updates in Hematologic Malignancies Debate: What is the most appropriate second line therapy for advanced follicular lymphoma patients who relapse following frontline R-CHOP? Craig Moskowitz, Andrew D. Zelenetz, MD, PhD
Debate: Should surveillance CT scans be performed on DLBC lymphoma patients who achieve a CR from frontline therapy? Andrew D. Zelenetz, MD, PhD
Debate: Should the results of interim PET scans change the planned management of advanced hodgkins lymphoma or diffuse large Craig Moskowitz
Emerging novel and promising therapeutic agents for AML Stephen Nimer
Debate: What is the most appropriate salvage therapy for post-imatinib failure in CML? Stephen Nimer
June 27, 2008 American Society of Clinical Oncology General Session III: Gastrointestinal (Colorectal) Cancer David P Kelsen
General Session X: Gynecologic Cancer David M Spriggs
May 30, 2008 ASCO Annual'08 Meeting general oncology sessions-- The Growing Challenge of CNS Metastases: New Therapeutic Approaches Lauren E. Abrey
general oncology sessions-- Integrating the Humanistic and Scientific Aspects of Patient Care: The Perspective of Seasoned Surgical, Medical, Pediatric, and Radiation Oncologists Teresa Gilewski
breast cancer-- Chemotherapy-Induced Cognitive Impairment (M06) Tim A Ahles
central nervous system tumors-- Chemotherapy-Induced Cognitive Impairment (M06) Tim A Ahles
central nervous system tumors-- The Growing Challenge of CNS Metastases: New Therapeutic Approaches Lauren E. Abrey
clinical trials-- Patient-Reported Outcomes in Oncology Ethan M. Basch
gynecologic cancer-- Benefit of Multimodality Management of Advanced Sarcoma: Why the Medical Oncologist Should Not Work Alone Murray F. Brennan
head and neck cancer-- Physiologic Response Imaging in Head and Neck Cancer Clifton Ling
health services research-- Patient-Reported Outcomes in Oncology Ethan M. Basch
lymphoma and plasma cell disorders-- Prognosis, Risk Stratification, and Treatment of Diffuse Large B-Cell Lymphoma: Incorporation of New Imaging Modalities and Molecular Markers (CPO11A) Andrew David Zelenetz
lymphoma and plasma cell disorders-- Prognosis, Risk Stratification, and Treatment of Diffuse Large B-Cell Lymphoma: Incorporation of New Imaging Modalities and Molecular Markers (CPO11B) Andrew David Zelenetz
patient and survivor care-- Patient-Reported Outcomes in Oncology Ethan M. Basch
patient and survivor care-- Integrating the Humanistic and Scientific Aspects of Patient Care: The Perspective of Seasoned Surgical, Medical, Pediatric, and Radiation Oncologists Teresa Gilewski
professional development-- Integrating the Humanistic and Scientific Aspects of Patient Care: The Perspective of Seasoned Surgical, Medical, Pediatric, and Radiation Oncologists Teresa Gilewski
sarcoma/bone and soft tissue cancers-- Benefit of Multimodality Management of Advanced Sarcoma: Why the Medical Oncologist Should Not Work Alone Murray F. Brennan
tumor biology-- Physiologic Response Imaging in Head and Neck Cancer Clifton Ling
meet the professor sessions-- Chemotherapy-Induced Cognitive Impairment (M06) Tim A Ahles
clinical problems in oncology-- Prognosis, Risk Stratification, and Treatment of Diffuse Large B-Cell Lymphoma: Incorporation of New Imaging Modalities and Molecular Markers (CPO11A) Andrew David Zelenetz
clinical problems in oncology-- Prognosis, Risk Stratification, and Treatment of Diffuse Large B-Cell Lymphoma: Incorporation of New Imaging Modalities and Molecular Markers (CPO11B) Andrew David Zelenetz
July 21, 2007 Hematopoietic Malignancies Insights into AML1-ETO gains-of-function Stephen Nimer
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.